Metabolic & Cardiometabolic · Gut & Microbiome
Lactobacillus paracasei W8 increases GLP-1
In plain terms: Does the probiotic L. paracasei boost the appetite-and-blood-sugar hormone GLP-1?
Unclear — evidence is mixed; the main trial found no effect on the hormone, appetite, or blood sugar.
📅 Last reviewed: 2026-07-15 ⓘ
Evidence ladder
How far up the ladder this claim has climbed. A high consensus on a low rung means "consistent so far," not "proven in people."
Top evidence so far: Human trials (RCT / n-of-1)
How the studies fall
What the evidence shows
L. paracasei W8 had NO effect on GLP-1, glucose, insulin, appetite or energy intake in a 4-wk RCT (n=64) — a Lactobacillus is not automatically a GLP-1 booster; strain-specificity is real.
The evidence (12)
| Source | Grade | Stance | Quality | Finding |
|---|---|---|---|---|
| Potrykus 2025 · Nutr | RCT | tested-null | low | 12-wk preoperative probiotic vs placebo: no clear benefit on gastrointestinal peptides (incl. incretins) 6 mo post-bariatric surgery. |
| NabizadehAsl 2022 · Appetite | RCT | tested-null | high | DB crossover: L. paracasei subsp. paracasei 431 +/- inulin did not robustly raise satiety hormones; effects on GLP-1 not significant. |
| Xu 2025 · Curr Microbiol | animal | mixed | low | L. paracasei Glu-07 characterized as anti-T2DM candidate via microbiota/metabolic pathways; GLP-1 stimulation inferred mechanistically, not measured in humans. |
| Bjerg 2015 · Benef Microbes | RCT | tested-null | moderate | W8 lowered triacylglycerol independent of colonisation; no GLP-1 benefit |
| Li 2024 · Nutrients | observational | mixed | low | Review of antidiabetic probiotics: some Lactobacillus strains improve incretin/insulin signaling, but GLP-1 elevation is strain- and host-dependent. |
| Zeng 2024 · mBio | observational | mixed | low | Review of microbiota-GLP-1 crosstalk: SCFA/bile-acid/TGR5 routes can modulate GLP-1, but specific Lactobacillus strains give inconsistent human GLP-1 effects. |
| Nilsson 2016 · Clin Nutr ESPEN | RCT | tested-null | high | Co-ingesting commercial probiotics with barley did not enhance gut-hormone (GLP-1) or appetite responses beyond fiber fermentation alone. |
| Xiang 2025 · Front Nutr | meta-analysis | tested-null | low | SR/MA: probiotic supplementation improved islet beta-cell function/glycemia in glucose-metabolism disorders; direct GLP-1 elevation not consistently shown. |
| Bjerg AT et al] # corrected 2026-08-17 from PubMed; was [(L. paracasei W8 RCT) 2015 · Benef Microbes | RCT | tested-null | moderate | n=64 RCT: no effect on GLP-1/glucose/insulin/appetite; only modest TAG drop |
| Simon MC, et al. (Holst) 2015 · Diabetes Care | RCT | supports | high | Proof-of-concept RCT: L. reuteri (not paracasei) increased GLP-1/GLP-2 and insulin secretion in glucose-tolerant humans - strain-specific, not W8. |
| Bjerg 2014 · Appetite | RCT | tested-null | moderate | L. paracasei W8 suppressed energy intake but no significant GLP-1 effect; single network |
| Chowdhury 2014 · Am J Physiol Gastrointest Liver Physiol | RCT | contradicts | high | Endogenous GLP-1 may not be a major insulin-secretion enhancer under physiological human conditions - tempers GLP-1-centric probiotic claims. |
Disagree, or know a study we missed?
We grade by evidence, not opinions. The way to weigh in is to point us to a study we haven't cited (check the evidence table above first), or to flag a problem with one we have. Every submission is reviewed; if it holds up, the grade updates and shows in Science Changes Its Mind.
Opens a short form. You'll sign in with Google so submissions are tied to a real account — we don't display your identity, and we only accept a link we can verify (PubMed, DOI, ClinicalTrials.gov).
Educational only, not medical advice. Grades and scores reflect published evidence weighted by study design and quality; see the methodology.